chr2-73424526-C-T
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS1
The NM_001378454.1(ALMS1):c.861C>T(p.Asp287Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00023 in 1,611,382 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001378454.1 synonymous
Scores
Clinical Significance
Conservation
Publications
- Alstrom syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152188Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000133 AC: 33AN: 247824 AF XY: 0.000112 show subpopulations
GnomAD4 exome AF: 0.000228 AC: 332AN: 1459194Hom.: 1 Cov.: 31 AF XY: 0.000205 AC XY: 149AN XY: 725510 show subpopulations
GnomAD4 genome AF: 0.000250 AC: 38AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.000350 AC XY: 26AN XY: 74344 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
- -
Variant summary: ALMS1 c.861C>T (alternative c.864C>T) alters a non-conserved nucleotide resulting in a synonymous change. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant is found in the gnomAD database at a frequency of 0.00014. This frequency is not higher than expected for a pathogenic variant in ALMS1 causing Cardiomyopathy (0.00014 vs 0.0022), allowing no conclusion about variant significance. The c.861C>T variant has been reported in the literature in one individual affected with Alstrom syndrome. This report does not provide unequivocal conclusions about an association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -
not provided Benign:2
- -
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Alstrom syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at